Skip to main content
RCEL
NASDAQ Industrial Applications And Services

AVITA Medical restructures PermeaDerm deal, securing a higher revenue share, a $500K expansion option, and a $1M minimum for 2026

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$8.2
Mkt Cap
$253.6M
52W Low
$3.22
52W High
$8.35
52W Position info
155% above low
Off High info
1.8% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

RCEL has more than doubled off its 52-week low of $3.22 on elevated volume (1.9× avg).

Summary

AVITA Medical amended its PermeaDerm agreements with Stedical Scientific, increasing its revenue share to 67–80%, paying $500K for an option to expand into Europe/UK/Australia, and committing to $1M in minimum revenue-sharing payments in 2026, growing 20% annually through 2030.


Key Events · M&A and Partnerships · RCEL

  • Global Amendment Signed

    On August 5, 2026, AVITA Medical and Stedical Scientific entered a Global Amendment to their existing distribution and manufacturing agreements for PermeaDerm, effective immediately.

  • Revenue Share Increased

    The revenue share for PermeaDerm rises to 67% for sheet-form products, with additional gross margin participation above 50%, and to 80% for glove-form products, with additional participation above 35% gross margin.

  • $500K Expansion Option

    A $500,000 fee secures the right of first offer and refusal to expand the exclusive distribution territory into the European Union, United Kingdom, and/or Australia, payable by January 15, 2027.

  • 2026 Minimum Revenue Sharing of $1M

    The amendment sets a $1.0 million minimum revenue-sharing payment for 2026, with 20% annual growth minimums through 2030, and waives all prior minimum payment requirements.


Analysis · RCEL · Industrial Applications And Services

AVITA Medical has restructured its PermeaDerm distribution and manufacturing agreements with Stedical Scientific, locking in a larger slice of product revenue—67% on sheet-form and 80% on glove-form sales—alongside a $500,000 option to expand into Europe, the UK, or Australia. The deal also establishes a $1.0 million minimum revenue-sharing payment for 2026, escalating 20% annually through 2030, and permits Stedical to enter certain U.S. markets that AVITA does not currently serve. By securing more favorable economics for its core wound-care product and opening a path to international markets, the amendment directly addresses the going-concern risk through a strengthened key revenue stream.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RCEL was trading at $8.20 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $253.6M. The 52-week trading range was $3.22 to $8.35. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RCEL - Latest Insights

RCEL
Nov 05, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $17.70
Real-time Price: $15.63 info
Change: -$2.07 (-12%) info
Market Cap: $491.098M info
RCEL
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.91
Real-time Price: $15.63 info
Change: -$2.28 (-13%) info
Market Cap: $491.098M info
RCEL
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $16.65
Real-time Price: $15.63 info
Change: -$1.02 (-6%) info
Market Cap: $491.098M info
RCEL
Aug 18, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $15.63 info
Change: +$7.13 (+84%) info
Market Cap: $491.098M info
RCEL
Aug 06, 2026, 10:55 PM EDT
Source: Small Caps
Importance Score:
8
Price at Filing: $5.65
Real-time Price: $15.63 info
Change: +$9.98 (+177%) info
Market Cap: $491.098M info